VIM and systemic sclerosis: In addition, HUVECs treated with the EVs from complicated SSc patients showed a reduced CD31 and VE-cadherin expression and an increased vimentin and N-cadherin expression in comparison with those found in HUVECs treated with EVs from uncomplicated SSc patients (Figure 12, Table 2).